Quantcast
Last updated on April 18, 2014 at 10:16 EDT

Latest antibodies Stories

2012-10-04 02:26:24

LA JOLLA, Calif., BREDA, Netherlands and GHENT, Belgium, Oct. 4, 2012 /PRNewswire/ -- RuiYi (formerly Anaphore) and arGEN-X BV announced today that arGEN-X has granted a worldwide exclusive license to RuiYi to develop and commercialize ARGX-109, a novel anti-IL-6 monoclonal antibody discovered and developed by arGEN-X. Under the agreement, RuiYi will make an upfront payment to arGEN-X consisting of cash and equity. arGEN-X is also eligible to receive additional payments based on the...

2012-10-04 02:26:19

LA JOLLA, Calif. and SHANGHAI, Oct. 4, 2012 /PRNewswire/ -- Anaphore announced today that its corporate name has changed to RuiYi. As part of the company's shift in strategy to the discovery and development of novel biologic therapies in China, including monoclonal antibodies that target G protein coupled receptors (GPCRs), RuiYi has also added three seasoned leaders to its management team in Shanghai. "RuiYi's new direction will enable us to focus on building our capabilities in...

2012-10-01 02:31:12

NEWCASTLE UPON TYNE, England, October 1, 2012 /PRNewswire/ -- Leica Biosystems [http://www.leicabiosystems.com/products/total-histology/novocastra-reagents/novocastra-hd ] announces the availability of the Novocastra(TM) HD menu for breast pathology, the first portfolio of independently qualified* antibodies from the new Novocastra HD range. Together with the FDA approval of the Leica BOND Oracle HER2 IHC System on April 18, 2012, this new menu affirms Leica Biosystems'...

2012-09-24 02:27:38

IRVINE, Calif., Sept. 24, 2012 /PRNewswire/ -- GeneTex, a leading manufacturer and supplier of antibodies and antibody-related reagents, announced an exclusive distribution agreement for North America with VWR, making GeneTex one of the premier antibody suppliers to VWR. (Logo: http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b) The extensive GeneTex product portfolio of more than 52,000 antibodies with more than 15,000 unique targets is now conveniently accessible to top...

2012-09-24 02:26:08

SAN DIEGO, Sept. 24, 2012 /PRNewswire/ -- Genalyte, Inc. today announced that it is hosting a webinar to show participants how they can generate multiplexed autoantibody assay results in a one-step, 15 minute process. Genalyte's Maverick(TM) Detection System uses a silicon chip containing arrays of photonic ring sensors that simultaneously analyze multiple antibodies and other proteins from a single small sample. The webinar, Chip-Based Multiplex Autoantibody Detection, is scheduled for...

2012-09-19 02:29:40

SEATTLE, Sept. 19, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute of Mental Health (NIMH) awarded a grant to the Company for its proprietary antibody discovery (DTLacO) platform. With this approximately $700,000 NIMH award, Omeros will use its DTLacO platform to develop antibodies targeting orphan G protein-coupled receptors (GPCRs) that are associated with neurological disorders. Omeros' proprietary DTLacO technology is an efficient ex...

Bacteria May Signal Risk For Pancreatic Cancer
2012-09-18 11:16:37

Pancreatic cancer is highly lethal and difficult to detect early. In a new study, researchers report that people who had high levels of antibodies for an infectious oral bacterium turned out to have double the risk for developing the cancer. High antibody levels for harmless oral bacteria, meanwhile, predicted a reduced pancreatic cancer risk. A new study finds significant associations between antibodies for multiple oral bacteria and the risk of pancreatic cancer, adding support for the...

2012-09-17 22:21:22

LEXINGTON, Mass., Sept. 18, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the digestive tract, announced today that the company was awarded U.S. Patent 8,268,971, entitled "Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity." The patent covers milk derived antibody compositions that specifically target and modulate an apical intestinal...

2012-09-17 22:21:14

CAMBRIDGE, England, September 18, 2012 /PRNewswire/ -- First human antibody strain from its advanced discovery platform Kymab, a monoclonal antibody biopharmaceutical company, announced today the launch of Kymouse HK, the first strain from the innovative Kymouse(TM) antibody discovery platform, which enables rapid discovery of high affinity antibody drug candidates. Kymouse HK is a transgenic mouse that has been designed to produce a diverse repertoire...

2012-09-17 13:55:41

Ads in Craigslist lead to potential medical advance Scientists from The Scripps Research Institute and Sea Lane Biotechnologies have solved the co-crystal structure of a human antibody that can neutralize influenza viruses in a unique way. The antibody recognizes the crucial structure that flu viruses use to attach to host cells, even though previously this structure had been thought too small for an antibody to grab effectively. The immune protein manages to hit this precise spot by using...